Top Markets
#1 Official Trump Official Trump +34.04%
#2 Siacoin Siacoin +30.62%
#3 Melania Meme Melania Meme +20.35%
#4 EXOD EXOD +18.93%
#5 MowCat MowCat +18.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +18.42%
#7 Mubarak Mubarak +17.66%
#8 Unit Pump Unit Pump +17.61%
#9 Pump.fun Pump.fun +17.61%
#10 The Bitcoin Bull The Bitcoin Bull +14.61%
Coin of the day
Official Trump Official Trump
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Rang in Aktien #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Aktienkurs
$4.00
Zuletzt synchronisiert: 2026-08-20
Marktkapitalisierung
$75.37M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
12.99%
Land
US
Handel RetinalGenix Technologies Inc. (RTGN)

Kategorie

Healthcare
P/B-Verhältnis für RetinalGenix Technologies Inc. (RTGN)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von RetinalGenix Technologies Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für RetinalGenix Technologies Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE